205 related articles for article (PubMed ID: 10439166)
61. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers.
Rege S; Maass A; Chaiken L; Hoh CK; Choi Y; Lufkin R; Anzai Y; Juillard G; Maddahi J; Phelps ME
Cancer; 1994 Jun; 73(12):3047-58. PubMed ID: 8200003
[TBL] [Abstract][Full Text] [Related]
62. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy.
Bailet JW; Abemayor E; Jabour BA; Hawkins RA; Ho C; Ward PH
Laryngoscope; 1992 Mar; 102(3):281-8. PubMed ID: 1545657
[TBL] [Abstract][Full Text] [Related]
63. FDG-PET in radiotherapy treatment planning of advanced head and neck cancer--a prospective clinical analysis.
Dietl B; Marienhagen J; Kühnel T; Schaefer C; Kölbl O
Auris Nasus Larynx; 2006 Sep; 33(3):303-9. PubMed ID: 16497462
[TBL] [Abstract][Full Text] [Related]
64. The Feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck.
Kim SY; Lee SW; Nam SY; Im KC; Kim JS; Oh SJ; Ahn SD; Shin SS; Choi EK; Kim JH
J Nucl Med; 2007 Mar; 48(3):373-8. PubMed ID: 17332614
[TBL] [Abstract][Full Text] [Related]
65. [Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors].
Rahn AN; Baum RP; Adamietz IA; Adams S; Sengupta S; Mose S; Bormeth SB; Hör G; Böttcher HD
Strahlenther Onkol; 1998 Jul; 174(7):358-64. PubMed ID: 9689957
[TBL] [Abstract][Full Text] [Related]
66. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Lassen U; Daugaard G; Eigtved A; Damgaard K; Friberg L
Eur J Cancer; 1999 Jul; 35(7):1076-82. PubMed ID: 10533451
[TBL] [Abstract][Full Text] [Related]
67. [Contribution of 18FDG PET/CT post treatment surveillance of head and neck squamous cell carcinoma].
Fakhry N; Barberet M; Paris J; Jacob T; Deveze A; Mundler O; Giovanni A; Zanaret M
Ann Otolaryngol Chir Cervicofac; 2006 Sep; 123(4):167-74. PubMed ID: 17088703
[TBL] [Abstract][Full Text] [Related]
68. FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
Conessa C; Hervé S; Foehrenbach H; Poncet JL
Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):628-35. PubMed ID: 15330142
[TBL] [Abstract][Full Text] [Related]
69. 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
Stokkel MP; Moons KG; ten Broek FW; van Rijk PP; Hordijk GJ
Cancer; 1999 Dec; 86(11):2370-7. PubMed ID: 10590380
[TBL] [Abstract][Full Text] [Related]
70. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET.
Nam SY; Lee SW; Im KC; Kim JS; Kim SY; Choi SH; Ryu JS; Moon DH; Oh SJ; Yi BY; Kim JH; Ahn SD; Shin SS; Kim SB; Choi EK; Lee BJ
Oral Oncol; 2005 Apr; 41(4):390-5. PubMed ID: 15792611
[TBL] [Abstract][Full Text] [Related]
71. FDG PET detection of unknown primary tumors.
Bohuslavizki KH; Klutmann S; Kröger S; Sonnemann U; Buchert R; Werner JA; Mester J; Clausen M
J Nucl Med; 2000 May; 41(5):816-22. PubMed ID: 10809197
[TBL] [Abstract][Full Text] [Related]
72. Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images.
Wong WL; Hussain K; Chevretton E; Hawkes DJ; Baddeley H; Maisey M; McGurk M
Am J Surg; 1996 Dec; 172(6):628-32. PubMed ID: 8988664
[TBL] [Abstract][Full Text] [Related]
73. The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancer.
Slevin NJ; Collins CD; Hastings DL; Waller ML; Johnson RJ; Cowan RA; Birzgalis AR; Farrington WT; Swindell R
J Laryngol Otol; 1999 Jun; 113(6):548-54. PubMed ID: 10605586
[TBL] [Abstract][Full Text] [Related]
74. [Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor].
Schipper JH; Schrader M; Arweiler D; Müller S; Sciuk J
HNO; 1996 May; 44(5):254-7. PubMed ID: 8707630
[TBL] [Abstract][Full Text] [Related]
75. Management of head and neck primary unknown squamous cell carcinoma using combined positron emission tomography-computed tomography and transoral laser microsurgery.
Kuta V; Williams B; Rigby M; Hart R; Trites J; MacKay C; Taylor SM
Laryngoscope; 2018 Oct; 128(10):2307-2311. PubMed ID: 29214640
[TBL] [Abstract][Full Text] [Related]
76. False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient.
Liu SH; Chang JT; Ng SH; Chan SC; Yen TC
Br J Radiol; 2004 Mar; 77(915):257-60. PubMed ID: 15020372
[TBL] [Abstract][Full Text] [Related]
77. Nonspecific FDG uptake in the tongue mimicking the primary tumor in a patient with cancer of unknown primary.
Werner MK; Pfannenberg C; Öksüz MÖ
Clin Imaging; 2011; 35(5):405-7. PubMed ID: 21872134
[TBL] [Abstract][Full Text] [Related]
78. Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck.
Salem S; Patel NH; Barwick T; Al-Nahhas A; Howard DJ; Zerizer I; Win Z
Clin Nucl Med; 2010 Oct; 35(10):800-1. PubMed ID: 20838291
[TBL] [Abstract][Full Text] [Related]
79. Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In regard to Rogers et al. (Int J Radiat Oncol Biol Phys 2004;58:694-697).
Yao M; Buatti JM; Dornfeld KJ; Graham MM; Smith RB; Funk GF; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):306-7; author reply 307. PubMed ID: 15629631
[No Abstract] [Full Text] [Related]
80. [Detection of residue of nasopharyngeal carcinoma with FDG PET].
Chen YR; Gu MX; Li WX; Pan Y
Ai Zheng; 2002 Jun; 21(6):651-3. PubMed ID: 12452068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
